干燥AMD的综合性景观病原,模型和新兴的治疗策略
Shiva Kumar Bhandari1, Sooyeun Lee1, Hye Jin Kim1
1College of Pharmacy, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Republic of Korea.
International journal of molecular sciences
|January 10, 2026
概括
干燥的与年龄相关的黄斑变性 (AMD) 是视力丧失的主要原因. 本综述详细介绍了AMD的机制,模型和新兴治疗方法,以指导未来的研究.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 干燥的与年龄相关的黄斑变性 (AMD) 是老年人不可逆转的视力丧失的主要原因,有效治疗方法有限.
- 与排泄性AMD不同,干性AMD进展缓慢,导致地理缩 (GA) 和显著的中央视力损伤.
- 目前FDA批准的治疗方法提供适度的益处,需要进一步研究潜在的机制和新的治疗策略.
研究的目的:
- 提供对驱动干燥AMD进展的分子和细胞机制的全面概述.
- 总结关键的致病途径,包括氧化应激,脂质失调,补充激活和脂素积累.
- 审查当前和新兴的治疗策略,并讨论干燥AMD的未来研究方向.
主要方法:
- 文献综述综合了关于干燥AMD病变的当前研究.
- 对干燥AMD涉及的分子和细胞机制的分析.
- 用于研究干燥AMD的机械化小鼠模型的摘要.
- 评估当前和新兴的治疗干预措施.
主要成果:
- 确定的主要致病途径包括氧化应激,脂质失调,补体激活,线粒体功能障碍和RPE脂素积累.
- 机械鼠标模型有助于了解疾病进展和评估治疗点.
- 新兴疗法包括补充抑制剂,视觉循环调节剂和线粒体保护剂.
结论:
- 对干性AMD复杂机制的更深入的理解对于开发有效治疗方法至关重要.
- 机械洞察力和疾病模型对于推进翻译研究至关重要.
- 未来的治疗开发应专注于针对干燥AMD的有针对性,特定阶段的干燥AMD干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.6K
11:12Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
887
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:26Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K
01:29Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:18Models of Health Promotion and Illness Prevention II
2.0K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
The agent-host-environment model states that disease results...
2.0K
01:20Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K